Altamira(EARS)

有望替代LNP！两家公司达成合作，应用基于肽的RNA递送平台研发mRNA疫苗

医麦客03-28 10:35

2024年3月28日
医麦客新闻 eMedClub News
近日，Altamira Therapeutics宣布与Univercells Group达成合作协议，以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用，SemaPhore平台有望代替LNP递送系统，在mRNA领域中有广泛地应用潜力。如果实验成功，Univercells和Altam...查看全文

财报披露

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-038350  Act: 34  Size: 11 KB 网页链接

财报披露

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-037820  Act: 34  Size: 13 KB 网页链接

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-032634  Act: 34  Size: 637 KB 网页链接

$Auris Medical(EARS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002228  Act: 33  Size: 2 KB 网页链接

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-030677  Act: 34  Size: 320 KB 网页链接

$Auris Medical(EARS)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001213900-21-030525  Act: 33  Size: 210 KB 网页链接

$Auris Medical(EARS)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001213900-21-030402  Act: 33  Size: 210 KB 网页链接

$Auris Medical(EARS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001213900-21-028265  Act: 34  Size: 47 KB 网页链接

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-026712  Act: 34  Size: 13 KB 网页链接

$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-021901  Act: 34  Size: 497 KB 网页链接